| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Aclidinium bromide/formoterol fumarate dihydrate |
| Brand | Brimica®/Genuair® |
| Indication | For treatment to relieve symptoms in adult patients with COPD. (Maintenance bronchodilator) |
| Assessment Process | |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Recommended at submitted price. |
The company has not submitted a HTA dossier to the NCPE therefore the cost effectiveness of the technology could not be proven.